Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06724861 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Sensory Rehabilitation in Chemo Induced Peripheral Neuropathy

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 years later Dec 11, 2024 → Dec 11, 2027
See other at-risk trials from Assaf-Harofeh Medical Center

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Dec 11, 2024 to Dec 11, 2027v2 Show 4 more changesShow less
    • Recruitment opened
    • Start date changed from estimate of Dec 11, 2024 to Apr 8, 2025
    • Study completion pushed from Dec 11, 2026 to Dec 11, 2027
    • Study site revised
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is a cross-over RCT evaluating the effectiveness of 3 sessions a week apart of explicit sensory retraining to the lower extremities in individuals with CIPN versus usual care. The primary outcome measures are TNAS for subjective symptoms, VAS for pain and TUG for mobility. Additional outcome measures are FABS for balance, sensory assessments - monofilaments for touch threshold, LEPT for proprioception, a home exercise log and a satisfaction questionnaire.
Trial Details
NCT Number NCT06724861
Lead Sponsor Assaf-Harofeh Medical Center
Collaborators: Zefat Academic College
Conditions
(from sponsor)		 CIPN - Chemotherapy-Induced Peripheral Neuropathy, Age Over 18, Chemotherapy-induced Peripheral Neuropathy
Related terms Neuralgia
Enrollment 27 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov